Alpha Teknova (NASDAQ:TKNO) & Azenta (NASDAQ:AZTA) Head to Head Comparison

Alpha Teknova (NASDAQ:TKNO – Get Free Report) and Azenta (NASDAQ:AZTA – Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership.

Insider & Institutional Ownership

13.8% of Alpha Teknova shares are owned by institutional investors. Comparatively, 99.1% of Azenta shares are owned by institutional investors. 13.2% of Alpha Teknova shares are owned by insiders. Comparatively, 10.9% of Azenta shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Alpha Teknova and Azenta’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Alpha Teknova -34.76% -24.95% -16.27%
Azenta -26.86% 1.41% 1.15%

Volatility and Risk

Alpha Teknova has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500. Comparatively, Azenta has a beta of 1.47, indicating that its stock price is 47% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current recommendations for Alpha Teknova and Azenta, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Teknova 1 1 4 0 2.50
Azenta 1 2 4 0 2.43

Alpha Teknova presently has a consensus price target of $8.75, suggesting a potential upside of 10.76%. Azenta has a consensus price target of $47.60, suggesting a potential upside of 1.82%. Given Alpha Teknova’s stronger consensus rating and higher possible upside, analysts clearly believe Alpha Teknova is more favorable than Azenta.

Valuation & Earnings

This table compares Alpha Teknova and Azenta”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Alpha Teknova $45.95 million 10.81 -$17.26 million ($0.29) -27.24
Azenta $621.70 million 3.29 -$166.99 million ($3.62) -12.91

Alpha Teknova has higher earnings, but lower revenue than Azenta. Alpha Teknova is trading at a lower price-to-earnings ratio than Azenta, indicating that it is currently the more affordable of the two stocks.

Summary

Azenta beats Alpha Teknova on 7 of the 13 factors compared between the two stocks.

About Alpha Teknova

(Get Free Report)

Alpha Teknova, Inc. develops and manufactures reagents used in life science research and the development and production of biopharmaceuticals and diagnostic products. Its offerings include cell culture media, buffers, molecular biology reagents, proteins and other laboratory materials. The company provides both catalog products and custom reagent development and manufacturing services. Its customers include biotechnology and pharmaceutical companies, diagnostic developers, academic institutions and research laboratories.

About Azenta

(Get Free Report)

Azenta, Inc. provides products and services for life sciences research and the management of biological samples. Its offerings include automated sample storage systems, laboratory automation equipment, consumables, and software used to track and manage samples. The company also provides genomic services through GENEWIZ, including sequencing and other genetic analysis services for researchers and organizations in the life sciences and pharmaceutical industries. Azenta was formed in 2021 when Brooks Automation separated its life sciences business and adopted the Azenta name.

Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.